Fundraising FoxAusperbio
2 known investors
Find your way into Ausperbio
Sign up to see every warm intro you have to Ausperbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ausperbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.
Founders & leadership
Investors · 2
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing
How we know: Qiming Venture Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
RA Capitallisted by RA CapitalBoston
How we know: racap.com · Not right? Tell us
Frequently asked questions
- What does Ausperbio do?
- AusperBio is a Phase II clinical-stage biopharmaceutical company developing oligonucleotide (ASO) therapeutics, with a focus on curative treatments for hepatitis B (HBV). It uses a proprietary Med-Oligo ASO platform and targeted delivery technologies to address viral infections, metabolic, genetic, and immune diseases.
- Who founded Ausperbio?
- Ausperbio was founded by Guofeng Cheng.
- Who are Ausperbio's investors?
- Ausperbio's investors include Qiming Venture Partners, RA Capital.